San José del Puente (MX)
{name}
{subtitle}
Placebo-controlled Study Comparing Niraparib Plus Pembrolizumab Versus Placebo Plus Pembrolizumab as Maintenance Therapy in Participants With Advanced/Metastatic Non-small Cell Lung Cancer
city
~7 mi. (México, Mexico, +151 more cities)
facility
GSK Investigational Site
condition
Non-Small Cell Lung Carcinoma
drug
niraparib, +1 more drug
drug type
immunotherapy, +1 more type
A Study of Nivolumab Plus Bempegaldesleukin (Bempeg/NKTR-214) vs Nivolumab Alone vs Standard of Care in Participants With Bladder Cancer That Has Invaded the Muscle Wall of the Bladder and Who Cannot Get Cisplatin, a Type of Medicine Given to Treat Bladder Cancer.
city
~7 mi. (México, Mexico, +137 more cities)
facility
Local Institution
condition
Bladder Urothelial Carcinoma
drug
bempegaldesleukin, +2 more drugs
drug type
immunotherapy, +2 more types
RaPiDS- A Phase 2 Study of Anti-PD-1 Independently or in Combination With Anti-CTLA-4 in Second-Line Cervical Cancer
city
~7 mi. (México, Mexico, +50 more cities)
facility
COI Centro Oncológico Internacional S.A.P.I. de C.V.
condition
Cervical Adenocarcinoma, +2 more conditions
drug
balstilimab, +2 more drugs
drug type
immunotherapy
A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer
city
~28 mi. (Mexico City, Mexico, +192 more cities)
facility
Grupo Medico Camino Sc
biomarker
ER Positive, +1 more biomarker
condition
Breast Carcinoma
drug
abemaciclib, +1 more drug
drug type
hormone therapy, +1 more type
Study of Nivolumab Versus Placebo in Combination With Neoadjuvant Chemotherapy and Adjuvant Endocrine Therapy in Participants With High-risk, Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor 2-Negative (HER2-) Primary Breast Cancer
city
~28 mi. (Mexico City, Mexico, +247 more cities)
facility
Local Institution
biomarker
ER Positive, +1 more biomarker
condition
Breast Invasive Ductal Carcinoma
drug
anthracycline, +4 more drugs
drug type
chemotherapy, +2 more types
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
city
~28 mi. (Mexico City, Mexico, +235 more cities)
facility
Instituto Nacional De Cancerologia de Mexico
condition
Prostate Adenocarcinoma
drug
abiraterone, +9 more drugs
drug type
hormone therapy, +2 more types